GEM

Indian Army Department Of Military Affairs Medicines Tender 2025 for Pyrazinamide Clotrimazole Fluconazole and Related Drugs

Posted

28 Oct 2025, 08:59 am

Deadline

07 Nov 2025, 09:00 am

Value

₹41,702

Progress

Issue28 Oct 2025, 08:59 am
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

46320

Category

Pyrazinamide 1500 mg tab

Bid Type

Two Packet Bid

Key Highlights

  • Pharmaceutical procurement scope covering 14 medicine items
  • Quantity variation up to 25% under option clause with extended delivery timing
  • Inclusion of injectable medicines (Methotrexate, Heparin) and IV solutions
  • Delivery timelines linked to original delivery order with calculated extensions
  • No explicit EMD amount provided in data; bidders must confirm amount and mode
  • No explicit IS/ISO standard numbers listed; prepare regulatory-compliant documentation
  • Prepare for comprehensive doc submission: GST, PAN, experience and financials
  • Item list includes antibiotics, antifungals, antiemetics, antivirals and CV/metabolic drugs

Categories 3

Tender Overview

Organization: Indian Army, Department Of Military Affairs. Procurement: multi-drug medical supply including Pyrazinamide 1500 mg tablets, Clotrimazole mouth paint, Fluconazole 150 mg cap/tab, Metronidazole 400 mg tab, Tinidazole 500 mg tab, Methotrexate sodium 50 mg/2 ml inj, Ondansetron 2 mg/ml 4 ml ampoule, Folic acid 5 mg tab, Heparin 5000 IU/ml inj, Atorvastatin 20 mg tab, Lignocaine HCl 2% solution IV use 50 ml, Enalapril Maleate 10 mg tab, Labetalol HCL 100 mg tab, Ivabradine 5 mg. Estimated value: ₹41,702.00. Location unspecified; tender targets ongoing procurement for medical supplies with 14 items. Unique clause allows quantity variation up to ±25% under the option clause, at contracted rates. Delivery schedule anchored to original order timelines; extended delivery time calculated per bid terms. This is a government procurement bid with standard vendor compliance expectations.

Technical Specifications & Requirements

  • Bill of Quantities (BOQ) indicates a total of 14 items; specific item quantities and units are not disclosed in the available data.
  • EMD/Security deposits: Not specified in the provided details.
  • Delivery terms: Option clause permits quantity variation up to 25% of bid/contracted quantity, with delivery extension calculations: (Additional quantity ÷ Original quantity) × Original delivery period, minimum 30 days.
  • Quality/standards: No explicit standard numbers (IS/ISO) mentioned in the data; bidders should infer standard pharmaceutical procurement practices per Army policy.
  • Product scope: Broad list includes antibiotics, antifungals, antiemetics, antidiabetics/vasodilators, and analgesic/antiarrhythmic agents, indicating a comprehensive medical supply contract.
  • Timeline: Delivery period tied to original delivery order; extended periods governed by option clause.
  • Experience/Capacities: Not stated explicitly; bidders should prepare documentation proving capability to supply listed medicines and injectables.
  • Packaging/Shipment: Not specified; assume standard pharmaceutical packaging and cold-chain requirements where applicable.
  • Warranty/After-sales: Not specified; bidders should seek clarification on AMC or warranty expectations if any.

Terms, Conditions & Eligibility

  • Quantity variation: Up to 25% increase or decrease at contract initiation and during currency at contracted rates.
  • Delivery extension: Calculated as (Increased quantity ÷ Original quantity) × Original delivery period; minimum 30 days.
  • Compliance: Bidders must adhere to buyer’s option clause and deliver as per original and extended timelines.
  • EMD/Payment terms: Not specified in the provided data; bidders should anticipate standard EMD and payment terms per Army procurement but must verify.
  • Documentation: GST, PAN, experience certificates, financial statements and any licensures relevant to pharmaceutical supplies may be required; verify TCs.
  • LIability penalties: Not detailed; bidders should confirm LD clauses during bid submission.
  • Other terms: All standard Army procurement terms apply; ensure alignment with local regulatory and medical supply norms.

Key Specifications

  • Total items: 14 medicines/injectables

  • Estimated value: ₹41,702.00

  • Option clause enabling ±25% quantity adjustment

  • Delivery extensions calculated as (additional/original) × original delivery period, min 30 days

  • IV/Injectable items included (Methotrexate, Heparin)

  • Synopsis only; detailed item-wise specs not provided

Terms & Conditions

  • Option clause allows ±25% quantity variation

  • Delivery period adjustments follow a defined formula with minimum 30 days

  • EMD and payment terms to be confirmed in tender TC

Important Clauses

Payment Terms

Not specified in data; verify in Terms & Conditions; expect standard Army procurement terms

Delivery Schedule

Delivery must commence from last date of original delivery order; extensions as per option clause

Penalties/Liquidated Damages

Not specified; bidders should confirm LD provisions in final TC

Bidder Eligibility

  • Demonstrated experience supplying pharmaceutical products, including injectables

  • GST registration and valid drug/medical supplier licences

  • Financial stability evidenced by recent financial statements

Bill of Quantities (BOQ) 14 Items

Item # Title Description Quantity Unit Consignee Delivery (Days)
1 Pyrazinamide 1500 mg tab Pyrazinamide 1500 mg tab 600 no consignee2@161mh 15
2 Clotrimazole mouth paint Clotrimazole mouth paint 300 bott consignee2@161mh 15
3 Fluconazole 150 mg cap and tab Fluconazole 150 mg cap and tab 1,200 no consignee2@161mh 15
4 Metronidazole 400 mg Tab Metronidazole 400 mg Tab 3,600 no consignee2@161mh 15
5 Tinidazole 500 mg Tab Tinidazole 500 mg Tab 3,000 no consignee2@161mh 15
6 Methotrexate sodium 50 mg 2 ml inj Methotrexate sodium 50 mg 2 ml inj 60 vial consignee2@161mh 15
7 Ondansetron 2mg ml 4ml amp inj Ondansetron 2mg ml 4ml amp inj 1,000 amp consignee2@161mh 15
8 Folic acid 5mg tab Folic acid 5mg tab 18,000 no consignee2@161mh 15
9 Heparin 5000 iu ml inj Heparin 5000 iu ml inj 60 vial consignee2@161mh 15
10 Atorvastatin 20 mg tab Atorvastatin 20 mg tab 10,000 no consignee2@161mh 15
11 Lignocaine HCL sol 2 percent for iv use 50ml inj Lignocaine HCL sol 2 percent for iv use 50ml inj 100 vial consignee2@161mh 15
12 Enalapril Maleate 10mg tab Enalapril Maleate 10mg tab 3,000 no consignee2@161mh 15
13 Labetalol HCL 100mg tab Labetalol HCL 100mg tab 4,800 no consignee2@161mh 15
14 Tab Ivabradine 5 mg Tab Ivabradine 5 mg 600 no consignee2@161mh 15

AI-Powered Bidder Prediction

Companies most likely to bid

Unlock Bidder Insights

AI predictions on likely bidders

Required Documents

1

GST certificate

2

PAN card

3

Experience certificates (pharmaceutical supply experience, especially injectable medications)

4

Financial statements for last 1-3 years

5

EMD documents (exact amount to be confirmed in TC)

6

Technical bid documents and product catalogues

7

OEM authorizations (where required for branded medicines)

8

Any required drug licences or regulatory approvals

Frequently Asked Questions

How to bid for medicines tender in Indian Army 2025?

Bidders must meet eligibility criteria including GST, PAN, and pharma supplier licensure. Prepare financial statements, experience certificates for supplying similar medicines, and OEM authorizations if branded drugs are offered. The tender allows ±25% quantity variation and has a defined delivery extension formula; submit all documents as per Terms.

What documents are required for Army medicines procurement 2025?

Submit GST certificate, PAN card, recent financial statements, experience certificates in pharmaceutical supply (especially injectables), EMD documents, technical bid, OEM authorizations, and any applicable drug licences. Ensure approvals cover Pyrazinamide, Fluconazole, Heparin and other listed drugs.

What are the key product items in this Indian Army tender?

The procurement includes Pyrazinamide 1500 mg tablets, Clotrimazole mouth paint, Fluconazole 150 mg, Metronidazole 400 mg, Tinidazole 500 mg, Methotrexate sodium, Ondansetron, Folic acid, Heparin, Atorvastatin, Lignocaine 2% IV solution, Enalapril, Labetalol, and Ivabradine 5 mg. Complete item list forms the 14-item BOQ scope.

What is the meaning of the option clause in this tender?

The option clause permits quantity changes up to ±25% of bid quantity during contract execution, with possible extension of delivery time calculated by a defined formula and a minimum 30 days. Bidders should plan for scalable supply and scheduling.

When is delivery time calculated for Army medicine supply?

Delivery begins after the last date of the original delivery order. If the option clause is exercised, additional time is (increased quantity/original quantity) × original delivery period, with a minimum of 30 days; the purchaser may extend within original delivery window.

What standards or regulatory compliance are expected for this bid?

No explicit IS/ISO standards are listed in data; bidders should maintain regulatory compliance for pharmaceutical procurement, pharmacovigilance readiness, and ensure licensing for injectables and anti-infectives; verify with tender TC for any standard requirements.

How is the estimated contract value disclosed for this tender?

The tender lists an estimated value of ₹41,702.00 for the 14-item medical supply package. Bidders should prepare pricing within contract rates and note that quantity variations may affect total contract value during execution.

What experience is required to participate in Army medicine tenders?

Proven capability to supply pharmaceutical products, especially injectables and critical care medicines, with documented purchase orders, delivery performance, and regulatory compliance. Provide reference letters or certificates showing similar medical supply contracts and financial stability.